Melanoma: experiência do Hospital de Clínicas de Porto Alegre - RS, de 1973 a 1990
DOI:
https://doi.org/10.32635/2176-9745.RBC.1993v39n1.2997Keywords:
Cancer, Skin Tumors, MelanomaAbstract
The more recent literature reports an incidence of melanoma growing up to 4% a year in the general population. Surgery remains the best hpo for cure and it's efficacy is associated with associated with neoplasm depth and timing of the procedure. The records of 159 consecutive patients submitted to surgical treatment at the Hospital de Clínicas de Porto Alegre from 1973 to 1990 were revewed. Data were collected regarding: localiza tion, macroscopic aspects, presence of the primary lesion and the presence of lymphatic and sistemic metastasis. Patients were staged in accordance with the criteria recommended by the American Joint Committee on Cancer (AJCC). There was no sex prevalence but most of the patients were caucasians. Mean age was 47,6 (± 17,5) years. Factor (hat commonly are related to a bad prognosis were identified in a great number of patients: 51,4% of the neo plasms were classified as stage III or IV, 32,2% were Clark V, in 68,5% the neoplasm depth was greater than 1,5 mm 46,5% had nodular aspect. The lymphatic drainage site was not identified in 30,8% of the cases. Lymphadenectomy was considered therapeutic in 72,6% of the cases and elective in 27,4%. In this particular group of patients refered to Hospital de Clínicas de Porto Alegre a high prevalence of factors related to bad prognosis was observed. The earlier diagnosis must be the reached by the promotion of educational programs for medical and general public and by the facilitation on the medical access.
Downloads
References
MORTON DL. Current management of malignant melanoma. Ann Surg 1990; 212(2): 123-4. DOI: https://doi.org/10.1097/00000658-199008000-00001
DAY CL, MIHM MC, SOBER AJ, FITZPATRICK TB, MALT RA. Narrower margins for clinical stage 1 malignant melanoma. N Engl J med 1982; 306(8): 479-2. DOI: https://doi.org/10.1056/NEJM198202253060810
MORTON DL, WANEK L, NIZZE JA, ELASHOFF RM, WONG JH. lmproved long-term survival after lymphadenectomy of melanoma metastatic toregional nodes. Analysis of prognostic factors in 1,134 patients from John Wayne Cancer Clinic. Ann Surg 1991; 214(4): 491-501. DOI: https://doi.org/10.1097/00000658-199110000-00013
BALCH CM, MURADTM, SOONG SJ, INGALLS AL, RICHARDS PC, MADDOX WA. Tumor thickness as a guide to surgical management of clinical stage 1 melanoma ptients. Cancer 1979; 3 (43): 883-8. DOI: https://doi.org/10.1002/1097-0142(197903)43:3<883::AID-CNCR2820430316>3.0.CO;2-V
FINCKSJ, GIUGLIANOAC, MANN BD, MORTON DL. Results of ilioinguinal dissection for stage II melanoma. Ann Surg 1982; 196(2): 180-6. DOI: https://doi.org/10.1097/00000658-198208000-00010
REITGEN DS, COX EB, McCARTY KS, VOLLMER RT, SEIGLER HF. Efficacy of elective lymph node dissection on patients with intermediatethikness primary melanoma. Ann Surg 1983; 198 (3): 379-85. DOI: https://doi.org/10.1097/00000658-198309000-00014
VERONESI U, ADAMUS J, BANDIERA DC et al. Delayad regional lymph node dissection in stage 1 melanoma of the skin of the lower extremities. Cancer 1982; 49(11): 2420-30. DOI: https://doi.org/10.1002/1097-0142(19820601)49:11<2420::AID-CNCR2820491133>3.0.CO;2-2
BEVILACQUA RG, COIT DG, ROGATKO A, YOUNES RN, BRENNAN MF. Axilary dissection in melanoma. Prognostic variables in node-positive patients. Ann Surg 1990; 212(2): 125-31. DOI: https://doi.org/10.1097/00000658-199008000-00002
COIT DG, BRENNAN MF. Extend of lymph node dissection in melanoma of the trunk or lower extremities. Arch Surg 1989; 124: 162-6. DOI: https://doi.org/10.1001/archsurg.1989.01410020032004
Skin, tumors and tumorlike conditions. In: ROSAI J. Ackerman's surgical pathology. St. Louis: C.V. Mosby Company 1989: 88-172.
BRESLOW A. Tumor thikness levei of invasion and node dissection in stage 1 cutaneous melanoma. Ann Surg 1975; 132: 572-5. DOI: https://doi.org/10.1097/00000658-197511000-00007
HOLMES EC, CLARKW, MORTON DL, EILBER FR, BOCHOW AJ. Regional lymph node metastasis and the levei of invasion of the primary melanoma. Cancer 1976; 37: 199-201. DOI: https://doi.org/10.1002/1097-0142(197601)37:1<199::AID-CNCR2820370128>3.0.CO;2-L
BEAH RS OH, MYERS MW eds. Manual for staging cancer, 2 ec. Philadelphia: JB Saunders, 1983.
BRESLOW A. Thikness coss sectionai area and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1981:193(3): 377-88.
CROWLEY NJ, SE1GLER HF. Late recurrence of malignant melanoma. Analysis of 168 patients. Ann Surg 1990:212(2): 173-7. DOI: https://doi.org/10.1097/00000658-199008000-00010
BALCH CM, SOONG SJ, MURAD TM, INGALLS AL, MADDOX WA. A multifactorial analysis of maianoma: III. Prognostictactors in melanoma patients with lymph node metastases (stage II). Ann Surg 1981; 193 (3): 377-88. DOI: https://doi.org/10.1097/00000658-198103000-00023
ROBINSON DS, SAMPLE WF, FEE HJ et al. Regional lymphatic drainage in primary malignant melanoma of the trunk determined bycoiloidal gold scanning. Surg Forum 1977; 28: 147-8.
HOLMES EC, MOSELEY HS, MORTON DL et al. A rational approach to the surgical management of melanoma. Ann Surg 1977; 186: 481-90. DOI: https://doi.org/10.1097/00000658-197710000-00010
MEYER CM, LECKL1TNER ML, LOGiCJR, BALCH CE, BESSEY PQ, TAUXE WN. Technetium-99m sulfur-coiloid cutaneous lymphoscintigraphy in the management of truncal melanoma. Radiology 1979; 131: 205-9. DOI: https://doi.org/10.1148/131.1.205
PATEL JK, DIDOLKAR MS, PICKREN JW, MOORE RH. Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg 1978; 135: 807-10. DOI: https://doi.org/10.1016/0002-9610(78)90171-X
REES MV, ROBINSON DS, HOLMES EC, MORTON DL. Altered lymphatic drainage following iymphadenectomy. Cancer 1980; 45(2): 3045-9. DOI: https://doi.org/10.1002/1097-0142(19800615)45:12<3045::AID-CNCR2820451228>3.0.CO;2-Y
WONG JH, CAGLE LA, MORTON DL. Surgical treatment of lymph nodes with metastatic melanomafrom unknown primary site. Arch Surg 1987; 122: 1380-3. DOI: https://doi.org/10.1001/archsurg.1987.01400240026003
ROSES DF, PROVETJA, HARR1S MN, GUMPORT SL, DUBIN N. Prognosis of patients with pathologic stage li cutaneous malignant melanoma. Ann Surg 1983:201(1): 103-7. DOI: https://doi.org/10.1097/00000658-198520110-00015
BALCH CM, SOONG SJ, MURAD TM, INGALLS AL, MADDOX WA. A multifactorial analysis of melanoma: li prognostic factors in patients with stage 1 (localized) melanoma. Surg 1979; 86(2): 343-51.
SWTHERLAND CM, MATHER FJ, KREMENTZ ET. Factors influencing the survival of patients with relional melanoma of the extremity treated by perfusion. Surg Gynecol Obstet 1987; 164: 111-8.
MORTON DL, WEN DR, WONG JH et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-99. DOI: https://doi.org/10.1001/archsurg.1992.01420040034005
